DHPA

  • Home
  • About Us
    • Leadership
      • Executive Committee
      • Board Members
    • DHPA Members
    • Contact Us
    • Join Us
  • Advocacy
    • Patient Access to Independent GI Care
      • Colorectal Cancer Screening
    • Diversity Equity and Inclusion
    • Modernizing the Stark Law
    • Saving the IOASE
    • Pathology Services Utilization
  • Resources
    • CRC Screening
    • Independent GI Careers
    • Research
    • Fact Sheets
    • Letters to Policymakers
    • Leadership Webinar Series
  • Newsroom
    • Press Releases
    • DHPA in the News
    • GI News Round Up
  • Take Action

September 7, 2022

DHPA Comment Letter on MPFS Proposed Rule for Calendar Year 2023

DHPA provided a comment letter to the Centers for Medicare and Medicaid Services (CMS) on the Medicare Physician Fee Schedule (MPFS) Proposed Rule for Calendar Year 2023, that focused on five issues impacting Medicare beneficiaries’ access to high quality, affordable care for gastrointestinal conditions and diseases.

  1. DHPA asked that CMS finalize its proposals to expand Medicare coverage of CRC screening tests, while making clear in the Final Rule that colonoscopy is a critical first-line screening test, particularly in Medicare-age patients.
  2. DHPA urged CMS to compel Medicare Administrative Contractors to discontinue the inappropriate use of Local Coverage Articles (LCAs) to down-code certain complex biologic drugs, including drugs used to treat patients with serious gastrointestinal diseases such as Crohn’s disease or ulcerative colitis, and to insure that any such LCAs currently in effect are invalidated.
  3. DHPA asked CMS to make permanent CMS’s definition of “substantive portion” for split (shared) visits in the facility setting that is in effect for CY 2022 or, at the very least, redefine “substantive portion” to include either more than 50 percent of the medical decision-making by the physician or nonphysician practitioner (NPP) or more than 50 percent of the time spent by the physician or NPP.
  4. Starting with the year following the end of the COVID-19 Public Health Emergency (PHE), DHPA asked that CMS make permanent the flexibility to meet the “immediate availability” requirement for direct supervision through virtual presence using real-time, audio/video technology.
  5. DHPA requested that CMS support Congressional efforts to provide the physician community with relief from the impending payment cuts set to take effect on January 1, 2023.

Click here to read the full letter >>

Filed Under: Advocacy, Letters to Policymakers, Newsroom, Resources, Uncategorized

Member Spotlight

Adult Gastroenterology Associates is a single-specialty GI and hepatology practice serving Tulsa and much of Northeastern Oklahoma, with physicians who specialize in colon cancer screening, treatment of GERD, IBD, and treatment of diseases of the liver and pancreas.

Learn more at:
www.tulsagastro.com

Become a Member

    Is your practice interested in promoting and preserving accessible, high quality and cost-efficient care in the independent GI medical setting? Contact us today about joining DHPA.

    Recent News

    • The Value of Colonoscopy: The Gold Standard in Colorectal Cancer Screening (Video)

    • Colorectal Cancer: Am I at Risk? (Video)

    • The Value of Colonoscopy (Infographic)

    • Colorectal Cancer: Am I at Risk? (Infographic)

    • Value of Colonoscopy Spanish Translation (Infographic)

    • Colorectal Cancer: Am I at Risk? Spanish Translation (Infographic)

    • DHPA Recommends MACRA Improvements to Bipartisan Group of U.S. Representatives

    • New Study in Gastro Journal: GI Patients Consider Telehealth to be the Same as In-Person Visits

    • DHPA Comment Letter on OPPS/ASC Proposed Rule for Calendar Year 2023

    Digestive Health Physicians Association, Inc.
    10770 Columbia Pike, Suite 400
    Silver Spring, Maryland, 20901
    © 2020 DHPA

    Follow @DHPAnews
    Tweets by DHPAnews

    Copyright © 2023 · Executive Pro Theme on Genesis Framework · WordPress · Log in